Conducting clinical trials in five Eastern European countries (EU-EECs) with a focus on Bulgaria

References

• European Medicines Agency. Guideline for good clinical practice E6(R2), 2016 https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-good-clinical-practice-e6r2-step-5_en.pdf. (accessed January 31 2023).
   Google Scholar
• European Parliament and European Council. Regulation (EU) no 536/2014 of the European parliament and of the council of April 16 2014 on clinical trials on medicinal products for human use, and repealing directive 2001/20/EC text with EEA relevance. Directive 2001/20/EC Text with EEA relevance, 2014, OJ L 158, 27.5., p. 1–7. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32014R0536 (accessed January 31 2023).
   Google Scholar
• European Parliament and European Council. DIRECTIVE 2001/83/EC of the EUROPEAN PARLIAMENT aND of the COUNCIL of november 6, 2001, on the community code relating to medicinal products for human use. 2001, OJ L 311, 28.11., p. 67. https://health.ec.europa.eu/system/files/2016-11/dir_2001_83_cons_2012_en_0.pdf (accessed January 31 2023).
   Google Scholar
• EU Clinical Trials Register. https://www.clinicaltrialsregister.eu. 2023, accessed January 31 2023).
   Google Scholar
• Bulgarian Drug Agency. Annual activity reports 2002–2021, https://www.bda.bg/en/useful-links/138-about-bda-en/916-annual-reports-bda-en. (accessed January 31 2023)
   Google Scholar
• Benisheva-Dimitrova T. Advantages of conducting clinical trials in Bulgaria (1995–2009). Biotechnol Biotechnol Equip. 2010;24(4):1–12. doi: 10.2478/V10133-010-0091-6.
   Web of Science ®Google Scholar
• Kitov B, Borissov B, Benisheva T. Highlight recent changes to Bulgarian legislation. Reform of the Bulgarian pharmaceutical regulations. Raj R. 2000;11(5):338–339.
   Google Scholar
• European Parliament and European Council. DIRECTIVE 2001/20/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of April 4 2001. on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. 2001OJ L 121, 1.5., p. 34 https://health.ec.europa.eu/system/files/2016-11/dir_2001_20_en_0.pdf. (accessed 31 January 2023).
   Google Scholar
• Medicinal Products in Human Medicine Act. State Gazette 2007/SG/31/, amend. 2018/SG/91.
   Google Scholar
• European Commission. Impact on Clinical Research of European Legislation | ICREL Project | Fact Sheet | FP7 | CORDIS | European Commission, 2008 https://cordis.europa.eu/project/id/201002. (accessed January 31 2023).
   Google Scholar
• Hartmann M, Hartmann-Vareilles F. The clinical trials directive: how is it affecting Europe’s non-commercial research. PLOS Clin Trial. 2006;1(2):e13. doi: 10.1371/journal.pctr.0010013.
   PubMedGoogle Scholar
• Sándor-Bajusz KA, Kraut A, Baasan O, et al. Publication of clinical trials on medicinal products: follow-up on trials authorized in Hungary. Trials. 2022;23(1):330. doi: 10.1186/s13063-022-06268-y.
   PubMed Web of Science ®Google Scholar
• State Institute for Drug Control. Clinical Trials Procedures |ŠÚKL. https://www.sukl.sk/hlavna-stranka-1/english-version/clinical-trials/clinical-trials-procedures?page_id=1394. (accessed January 31 2023).
   Google Scholar
• Bulgarian Drug Agency. Requirements for clinical trials in Bulgaria, https://bda.bg/bg/62-business-info/clinical-examinations-biz/238-2010-03-18-14-41-50. (accessed January 31 2023).
   Google Scholar
• Association of Leading Clinical Trial Companies in Romania. Requirements for clinical trials in Romania, 2020. https://www.accscr.ro/images/upload/images/Clinical%20Trials%20Study%20Romania_20200827_RAPORT%20FINAL_RO.pdf. (accessed January 31 2023).
   Google Scholar
• European Medicines Agency. Clinical Trials Information System, https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials/clinical-trials-information-system#:∼:text=The%20Clinical%20Trials%20Information%20System%20(CTIS)%20supports%20the%20flow%20of,website%20on%2031%20January%202022. (accessed January 31 2023).
   Google Scholar
• Bulgarian Drug Agency. Local guidance on the document requirements for Part 2 of the clinical trial dossier. https://www.bda.bg/en/legal-acts/102-information-for-companies-section. (accessed January 31 2023).
   Google Scholar
• Medicinal Products in Human Medicine Act. April 13, 2007 SG/31/2007.
   Google Scholar
• Medicinal Products in Human Medicine Act. April 13, 2007 SG/31/2007 amend. SG/43/2016.
   Google Scholar
• Ordinance 31 of Bulgarian Ministry of Health. SG/67/2007. Last amend. SG/28/2021
   Google Scholar
• Eurostat. GDP per capita in PPS, https://ec.europa.eu/eurostat/databrowser/view/tec00114/default/table?lang=en. (accessed January 31 2023).
   Google Scholar
• EUROSTAT. Total population of the European Union, https://ec.europa.eu/eurostat/databrowser/view/DEMO_GIND__custom_5468764/bookmark/table?lang=en&bookmarkId=47b3db3a-b5e7-4a7b-a4ee-d61e2d1d259b. (2023, accessed January 31 2023).
   Google Scholar
• Jassem J, Schoket Z, Krzakowski M. Cancer clinical trials in Central and Eastern Europe: a historical review. Crit Rev Oncol Hematol. 2002;42(2):157–161.PMID: 12007973 doi: 10.1016/s1040-8428(01)00170-6.
   PubMed Web of Science ®Google Scholar
• Neal H. The contract research organization perspective: audits in Central and Eastern European countries. Drug Information J. 2001;35(2):475–480. doi: 10.1177/009286150103500216.
   Google Scholar
• Paál TL. Recent changes in clinical trial authorization in Eastern Europe. Drug Inf J. 1997;3131 (1):151–155. doi: 10.1177/009286159703100122.
   Google Scholar
• Borissov BN, Popova MJ, Koulaksazova RA. Transition challenges for collaboration agreement of drug regulatory authorities in European Union associated countries: focus on Bulgaria. Drug Information J. 2001;35: (3):935–939. doi: 10.1177/009286150103500332.
   Google Scholar
• Babic D, Kucerova I. Benchmarking clinical trials practices in Central and Eastern Europe. Appl Clin Trials. 2003;12:56–59.
   Google Scholar
• Platonov P, Escandon R, Varshavsky S. Recruitment rates and data quality: are they linked? Appl Clin Trials. 2003;11:32–35.
   Google Scholar
• Platonov P. Clinical trials in Russia and Eastern Europe: recruitment and quality. Int J Clin Pharmacol Ther. 2003;41(7):277–280. doi: 10.5414/cpp41277.
   PubMed Web of Science ®Google Scholar
• Sinackevich N, Tassignon JS. Speeding the critical path. Appl Clin Trials. 2004;9(4):52–59.
   Google Scholar
• Gebska MA, Hargreaves JR. Conducting clinical trials in Poland. Appl Clin Trials. 2000;9(4):52–59.
   Google Scholar
• Demeter J. Selecting sites and investigators. Appl Clin Trials. 2002;11:56–66.
   Google Scholar
• Karlberg JPE. West to east drift in European sponsored clinical trials. Clinical Trial Magnifier. 2008Vol; One/Issue 1:1–9.
   Google Scholar
• Novak T, Belotserkovsky M, Payeur G. Decline of trials in CEE: fluctuation or trend? Appl Clin Trials. 2015;24:14.
   Google Scholar
• Misik V, V Brady R, Bolecek M, et al. Current trends in globalization of industry-sponsored clinical trials. ACCTRA. 2014;1(1):56–66. doi: 10.2174/2213476X01666131111191016.
   Google Scholar
• Dombernowsky T, Hædersdal M, Lassen U, et al. Development in the number of clinical trial applications in Western Europe from 2007 to 2015: a retrospective study of data from competent national authorities. BMJ Open. 2017;7(7):e015579. PMID: 28698332 PMCID: PMC5734571, doi: 10.1136/bmjopen-2016-015579.
   PubMed Web of Science ®Google Scholar
• Hartmann M. Impact assessment of the European clinical trials directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries. Trials. 2012;13:53. doi: 10.1186/1745-6215-13-53.
   PubMed Web of Science ®Google Scholar
• Gelgand J, Dutchak K, J. CS. March. 2017. print. Market report clinical trials in Central & Eastern Europe: keeping up with global competition. J. Clin. Studies. 2017;9:36–38. ___indd (journalforclinicalstudies.com)
   Google Scholar
• EUROSTAT. Practising Physicians. https://ec.europa.eu/eurostat/databrowser/view/tps00044/default/table?lang=en. (accessed January 31 2023).
   Google Scholar
• Caldron PH, Gavrilova SI, Kropf S. Why (not) go east? Comparison of findings from FDA investigational new drug study site inspections performed in Central and Eastern Europe with results from the USA, Western Europe, and other parts of the world. Drug Des Dev Ther. 2012;6:53–60. doi: 10.2147/DDDT.S30109.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Annual Reports of the Good Clinical Practice Inspectors Working Group 2017–2021, https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-clinical-practice/good-clinical-practice-inspectors-working-group. (accessed January 31 2023).
   Google Scholar
• European Medicines Agency. Classification and analysis of the GCP inspection findings of GCP inspections conducted at the request of the CHMP, Inspection reports to EMA 2000-2012) https://www.ema.europa.eu/en/documents/other/classification-analysis-good-clinical-practice-gcp-inspection-findings-gcp-inspections-conducted_en.pdf. (accessed January 31 2023).
   Google Scholar
• Motteram PAS, Richardson A. Clinical trials in CEE: Harnessing the potential. Applied Clinical Trials-2004, 09-01, https://www.appliedclinicaltrialsonline.com/view/clinical-trials-cee-harnessing-potential. (accessed January 31 2023).
   Google Scholar
• 7 Reasons to include Eastern Europe in your Clinical Trial Strategy. (biomapas.com) (accessed January 31 2023).
   Google Scholar
• Abbas N, Hasan SS, Curley L, et al. Access to medication – a systematic review of the literature. Res Social Adm Pharm. 2020;16(9):1166–1176. Sepdoi: 10.1016/j.sapharm.2019.12.009.
   PubMed Web of Science ®Google Scholar
• Clinical Trials Register. 2021. Official website of Bulgarian Drug Agency at the Ministry of Health in Republic of Bulgaria REG_CT_BDA_2022-24.03.2023.xlsx (live.com)
   Google Scholar